Recombinant vaccine against Marek's disease and Ne
Poultry
Vaccine
Vaccine
Each dose of the Innovax ® ND product contains at least 1810 PFUs of live turkey herpesvirus, in the form of an associated cell, HVT strain, genetically modified with the insertion of the Newcastle disease virus protein F gene, with a minimum titre of 1802 PFUs , at the end of the product's validity period. Indications: Vaccine for active immunization in chicks to prevent Marek's disease and Newcastle disease.
Generic Name | Recombinant vaccine against Marek's disease and Ne |
Units | 2000 dose |
Product Dosage | INNOVAX ® ND should be administered at a dose of 0.2 ml per 1-day-old chick, via the subcutaneous route and at a dose of 0.05 ml via the “in ovo” route in embryonated chicken eggs of 18 days of incubation . |
Sorry, Document is not available till yet.